Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $27,695 | 14 | 49.4% |
| Honoraria | $14,500 | 10 | 25.9% |
| Travel and Lodging | $11,557 | 27 | 20.6% |
| Food and Beverage | $2,300 | 60 | 4.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $55,747 | 95 | $0 (2024) |
| Merck Sharp & Dohme LLC | $195.34 | 13 | $0 (2024) |
| VERTEX PHARMACEUTICALS INCORPORATED | $96.05 | 2 | $0 (2024) |
| Haemonetics Corporation | $14.03 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,385 | 22 | Pacira Pharmaceuticals Incorporated ($11,216) |
| 2023 | $19,109 | 27 | Pacira Pharmaceuticals Incorporated ($19,060) |
| 2022 | $23,484 | 49 | Pacira Pharmaceuticals Incorporated ($23,439) |
| 2021 | $2,035 | 11 | Pacira Pharmaceuticals Incorporated ($1,992) |
| 2019 | $39.15 | 2 | Pacira Pharmaceuticals Incorporated ($39.15) |
All Payment Transactions
111 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Consulting Fee | Cash or cash equivalent | $1,160.00 | General |
| Category: Pain Management | ||||||
| 12/03/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Honoraria | Cash or cash equivalent | $1,305.00 | General |
| Category: Pain Management | ||||||
| 11/20/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $65.43 | General |
| 11/14/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $115.94 | General |
| Category: Pain Management | ||||||
| 11/06/2024 | Haemonetics Corporation | TEG5000 HEMOSTASIS ANALYZER (Device) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: DEVICES | ||||||
| 10/29/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Honoraria | Cash or cash equivalent | $435.00 | General |
| Category: Pain Management | ||||||
| 10/16/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Pain Management | ||||||
| 09/18/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $30.62 | General |
| 07/30/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Consulting Fee | Cash or cash equivalent | $2,320.00 | General |
| Category: Pain Management | ||||||
| 07/23/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug), Iovera | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: Pain Management | ||||||
| 06/29/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: Pain Management | ||||||
| 06/29/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Pain Management | ||||||
| 06/28/2024 | Merck Sharp & Dohme LLC | BRIDION (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: NEUROSCIENCE | ||||||
| 04/23/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Consulting Fee | Cash or cash equivalent | $2,320.00 | General |
| Category: Pain Management | ||||||
| 04/22/2024 | Merck Sharp & Dohme LLC | BRIDION (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Honoraria | Cash or cash equivalent | $290.00 | General |
| Category: Pain Management | ||||||
| 03/27/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $13.50 | General |
| 02/24/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $25.84 | General |
| Category: Pain Management | ||||||
| 02/24/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $10.48 | General |
| Category: Pain Management | ||||||
| 01/26/2024 | Merck Sharp & Dohme LLC | BRIDION (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: NEUROSCIENCE | ||||||
| 01/18/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Consulting Fee | Cash or cash equivalent | $3,045.00 | General |
| Category: Pain Management | ||||||
| 01/18/2024 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Travel and Lodging | Cash or cash equivalent | $118.81 | General |
| Category: Pain Management | ||||||
| 12/09/2023 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Travel and Lodging | In-kind items and services | $610.53 | General |
| Category: Pain Management | ||||||
| 12/08/2023 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Travel and Lodging | In-kind items and services | $537.80 | General |
| Category: Pain Management | ||||||
| 10/24/2023 | Pacira Pharmaceuticals Incorporated | Iovera (Device) | Food and Beverage | In-kind items and services | $123.22 | General |
| Category: Pain Management | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 336 | 358 | $481,689 | $16,076 |
| 2022 | 5 | 123 | 123 | $155,661 | $4,230 |
| 2021 | 5 | 128 | 128 | $156,111 | $4,634 |
| 2020 | 5 | 88 | 89 | $107,392 | $3,070 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 93 | 98 | $104,566 | $2,406 | 2.3% |
| 64640 | Destruction of peripheral nerve or branch | Facility | 2023 | 15 | 27 | $57,834 | $2,066 | 3.6% |
| 64447 | Injection of anesthetic agent and/or steroid into thigh nerve (femoral nerve) | Facility | 2023 | 39 | 40 | $66,640 | $1,944 | 2.9% |
| 64999 | Other procedure on nervous system | Facility | 2023 | 74 | 75 | $44,958 | $1,803 | 4.0% |
| 64488 | Injection of local anesthetic for abdominal wall pain control on both sides using imaging guidance | Facility | 2023 | 32 | 32 | $44,640 | $1,707 | 3.8% |
| 01402 | Anesthesia for procedure for total knee joint replacement | Facility | 2023 | 16 | 16 | $37,193 | $1,617 | 4.3% |
| 00670 | Anesthesia for extensive surgery on spine | Facility | 2023 | 12 | 12 | $34,974 | $1,171 | 3.3% |
| 01916 | Anesthesia for x-ray exam of arteries and veins using contrast | Facility | 2023 | 12 | 13 | $21,272 | $1,043 | 4.9% |
| 00840 | Anesthesia for other procedure on lower abdomen | Facility | 2023 | 13 | 13 | $24,143 | $1,031 | 4.3% |
| 01844 | Anesthesia for placement or revision of blood flow shunt | Facility | 2023 | 12 | 12 | $18,270 | $929.23 | 5.1% |
| 64450 | Injection of anesthetic agent and/or steroid into other nerve or branch | Facility | 2023 | 18 | 20 | $27,200 | $358.04 | 1.3% |
| 64999 | Other procedure on nervous system | Facility | 2022 | 31 | 31 | $33,561 | $1,152 | 3.4% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2022 | 41 | 41 | $43,747 | $1,039 | 2.4% |
| 64488 | Injection of local anesthetic for abdominal wall pain control on both sides using imaging guidance | Facility | 2022 | 17 | 17 | $23,715 | $960.23 | 4.0% |
| 64447 | Injection of anesthetic agent and/or steroid into thigh nerve | Facility | 2022 | 23 | 23 | $38,318 | $801.45 | 2.1% |
| 64450 | Injection of anesthetic agent and/or steroid into other nerve or branch | Facility | 2022 | 11 | 11 | $16,320 | $277.86 | 1.7% |
| 64488 | Injections of local anesthetic for pain control and abdominal wall analgesia on both sides | Facility | 2021 | 28 | 28 | $39,060 | $1,565 | 4.0% |
| 64999 | Nervous system procedure | Facility | 2021 | 33 | 33 | $32,475 | $1,133 | 3.5% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Facility | 2021 | 38 | 38 | $40,546 | $983.44 | 2.4% |
| 64447 | Injection of anesthetic agent and/or steroid into femoral nerve of thigh | Facility | 2021 | 15 | 15 | $24,990 | $596.70 | 2.4% |
| 64450 | Injection of anesthetic agent and/or steroid into other peripheral nerve or branch | Facility | 2021 | 14 | 14 | $19,040 | $355.20 | 1.9% |
| 64488 | Injections of local anesthetic for pain control and abdominal wall analgesia on both sides | Facility | 2020 | 18 | 18 | $25,110 | $1,053 | 4.2% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Facility | 2020 | 24 | 24 | $25,608 | $634.88 | 2.5% |
| 64447 | Injection of anesthetic agent and/or steroid into femoral nerve of thigh | Facility | 2020 | 13 | 13 | $21,658 | $560.91 | 2.6% |
| 64450 | Injection of anesthetic agent and/or steroid into other peripheral nerve or branch | Facility | 2020 | 18 | 19 | $27,200 | $432.09 | 1.6% |
About Dr. Kelly Leblanc, MD
Dr. Kelly Leblanc, MD is a Anesthesiology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1639221229.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kelly Leblanc, MD has received a total of $56,052 in payments from pharmaceutical and medical device companies, with $11,385 received in 2024. These payments were reported across 111 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($27,695).
As a Medicare-enrolled provider, Leblanc has provided services to 675 Medicare beneficiaries, totaling 698 services with total Medicare billing of $28,010. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Anesthesiology
- Location Dallas, TX
- Active Since 01/17/2007
- Last Updated 07/28/2022
- Taxonomy Code 207L00000X
- Entity Type Individual
- NPI Number 1639221229
Products in Payments
- Exparel (Drug) $54,223
- Iovera (Device) $1,394
- BRIDION (Drug) $181.84
- Iovera System (Device) $90.91
- EXPAREL (Drug) $39.15
- TEG5000 HEMOSTASIS ANALYZER (Device) $14.03
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anesthesiology Doctors in Dallas
James Mueller, M.d, M.D
Anesthesiology — Payments: $753,569
Girish Joshi, Md, MD
Anesthesiology — Payments: $420,549
Dr. Peter Szmuk, Md, MD
Anesthesiology — Payments: $172,473
Dr. Richard Dutton, M.d, M.D
Anesthesiology — Payments: $89,445
Christina Riccio, M.d, M.D
Anesthesiology — Payments: $76,496
Dr. Michael Walsh, M.d, M.D
Anesthesiology — Payments: $65,832